TherapeuticsMD, Inc. (TXMD) stock
TXMDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026Score 12/3030% below fair value
$1.82−0.03 (-1.62%)
Close on Nov 12, 2026Market cap $21.07MP/E –Yield –
TherapeuticsMD enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
TherapeuticsMD's enterprise value was $12.22M on Nov 11, 2026, against $12.56M a year earlier. Over the last 5 years it ranged from -$15.69M to $286.72M, with a median of $16.13M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $12.22M | +4.0% |
| 2025 | Dec 31, 2025 | $11.75M | +141.3% |
| 2024 | Dec 31, 2024 | $4.87M | -64.3% |
| 2023 | Dec 29, 2023 | $13.63M | -83.3% |
| 2022 | Dec 30, 2022 | $81.40M | -65.3% |
| 2021 | Dec 31, 2021 | $234.85M | -51.8% |
| 2020 | Dec 31, 2020 | $487.52M | -21.7% |
| 2019 | Dec 31, 2019 | $622.92M | -20.6% |
| 2018 | Dec 31, 2018 | $784.19M | -32.3% |
| 2017 | Dec 29, 2017 | $1.16B | +17.5% |
| 2016 | Dec 30, 2016 | $986.73M | -44.0% |
| 2015 | Dec 31, 2015 | $1.76B | +181.0% |
| 2014 | Dec 31, 2014 | $627.34M | -9.8% |
| 2013 | Dec 31, 2013 | $695.68M | +181.8% |
| 2012 | Dec 31, 2012 | $246.87M | +181.5% |
| 2011 | Dec 30, 2011 | $87.71M | – |
See a number that looks wrong?